Natalizumab in the treatment of multiple sclerosis;Natalizumab en el tratamiento de la esclerosis multiple.

Revista de neurologia

Volumn 45, Issue 5, 2007, Pages 293-303

  Horga, A ^a   Horga de la Parte, J F ^a  

^a HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA4 INTEGRIN; BETA INTERFERON; BETA1A INTERFERON; MONOCLONAL ANTIBODY; NATALIZUMAB;

CLINICAL TRIAL; DISEASE COURSE; HUMAN; IMMUNOLOGY; METABOLISM; MULTIPLE SCLEROSIS; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; RECURRENT DISEASE; REVIEW; TREATMENT OUTCOME;

ANTIBODIES, MONOCLONAL; CLINICAL TRIALS AS TOPIC; DISEASE PROGRESSION; HUMANS; INTEGRIN ALPHA4; INTERFERON-BETA; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; MULTIPLE SCLEROSIS; RECURRENCE; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 37149001297     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.4505.2007268     Document Type: Review

References (48)